TF and breast carcinoma: We conclude that removal of a single EMT‐TF, ZEB1, from an established mesenchymal breast cancer cell, is not sufficient to revert the tumor cells into a more epithelial phenotype, as we also demonstrated for Snail1 and Twist1 in an independent breast cancer model (Tan et al., 2015).